FDA Guidance on CT Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
FDA issued this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.
Related Education Resources.
All ResourcesLeadership Lessons for Re-Entry
Topics: Leadership, Management
Webinar
Free
EAP 101: Introduction to EAP
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning, Project Management
Presentation
Members
Expanded Access: Past, Present and Future Improvements
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Position Paper
Free
